Predictors and benefits of lipid-lowering therapy initiation after an atherosclerotic cardiovascular event: a retrospective cohort study
This study underscores a suboptimal LLT initiation rate in post-ASCVD patients. Initiating LLT is associated with significantly reduced 1-year total mortality, highlighting the need to optimize secondary prevention strategies.
Authors
- А. С. Алиева (ORCID: https://orcid.org/0000-0002-9845-331X)
- Federica Galimberti (ORCID: https://orcid.org/0000-0002-4231-4150)
- Giorgio Lorenzo Colombo (ORCID: https://orcid.org/0000-0002-5790-8891)
- Manuela Casula (ORCID: https://orcid.org/0000-0002-5124-5361)
- Elena Olmastroni (ORCID: https://orcid.org/0000-0001-7107-243X)
- Stefano Scotti (ORCID: https://orcid.org/0009-0008-8881-5912)
- Giacomo Matteo Bruno (ORCID: https://orcid.org/0000-0003-4571-654X)
- Sining Xie (ORCID: https://orcid.org/0000-0003-2893-9135)
- Alberico L. Catapano (ORCID: https://orcid.org/0000-0002-7593-2094)
Institutions
- University of Milan (IT)
- University of Pavia (IT)
- Federal Almazov North-West Medical Research Centre (RU)
- MultiMedica (IT)
- Health Economics and Outcomes Research (United Kingdom) (GB)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-09-25
- DOI
- https://doi.org/10.3389/fphar.2025.1588376
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Ministero della Salute
- Regione Lombardia